Related Experiment Videos
Is the outlook changing for patients with renal cell cancer?
1Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, London, U.K.
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Epidemiological Data on Anaphylaxis in French Emergency Departments.
Journal of investigational allergology & clinical immunology·2018
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.
Nature communications·2018
Proton Therapy for Craniopharyngioma - An Early Report from a Single European Centre.
Clinical oncology (Royal College of Radiologists (Great Britain))·2018
The burden of seasonal respiratory infections on a national telehealth service in England.
Epidemiology and infection·2017
Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.
European journal of cancer (Oxford, England : 1990)·2026
Diagnostic pitfalls and unmet needs in neuroendocrine neoplasms: The added value of collegial expert pathology review through the national TENpath network.
European journal of cancer (Oxford, England : 1990)·2026
Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
European journal of cancer (Oxford, England : 1990)·2026
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
European journal of cancer (Oxford, England : 1990)·2026
Development of an age specific EORTC questionnaire to assess the health-related quality of life (HRQOL) of children with cancer aged 8-14 years - a mixed-methods content elicitation phase I & II EORTC QLG study.
European journal of cancer (Oxford, England : 1990)·2026
Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial.
European journal of cancer (Oxford, England : 1990)·2026